<DOC>
	<DOCNO>NCT00004744</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether high-dose intravenous immune globulin ( IVIG ) effective placebo restore neurologic function ( muscle strength ) patient multiple sclerosis . II . Determine time recovery follow IVIG .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Intravenous Immune Globulin Multiple Sclerosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients treat intravenous immune globulin placebo . In absence hypersensitivity reaction test dose , total 11 dos administer : daily 5 day , every 2 week 12 week . Patients follow 3 month .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Clinically laboratorysupported definite multiple sclerosis Disease relapsingremitting relapsingprogressive ( i.e. , secondary progressive ) Targeted neurologic deficit follow : 25 % loss power least 1 limb Severity 1 great Mayo Clinic rating scale OR Between 3+/5 4/5 Medical Research Clinic muscle power scale Documented Mayo Clinic Department Neurology neither progress improve 4 18 month prior entry No clinical evidence spontaneous corticosteroidinduced improvement Able cooperate isometric strength test requirement Prior/Concurrent Therapy No concurrent experimental drug therapy No concurrent intravenous immune globulin At least 3 month since immunosuppressive therapy , e.g. , corticosteroid corticotropin At least 3 month since plasma exchange Patient Characteristics Hepatic : No coagulation defect , e.g. , hyperviscosity syndrome Renal : Creatinine great 1.5 time normal Cardiovascular : No unstable advanced ischemic cerebrovascular disease , e.g . : angina congestive heart failure transient ischemic attack stroke Immunologic : No human gamma globulin albumin sensitivity No hypergammaglobulinemia No know antibody deficiency syndrome , especially IgA deficiency Other : No condition interfere neurologic exam , e.g . : Major amputation Deforming arthritis Major psychiatric illness Superimposed low motor neuron deficit No intellectual impairment preclude study participation No pregnant nursing woman Adequate contraception require fertile patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>